| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5577926 | The Journal of Pain | 2017 | 68 Pages |
Abstract
The applicability of sensory testing, skin biopsy, and brain imaging as diagnostic, prognostic, predictive, and pharmacodynamic biomarkers for use in analgesic treatment trials is considered. Evidence in support of their use and outlining problems is presented, as well as a call for further standardization and demonstrations of validity and reliability.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Shannon M. Smith, Robert H. Dworkin, Dennis C. Turk, Ralf Baron, Michael Polydefkis, Irene Tracey, David Borsook, Robert R. Edwards, Richard E. Harris, Tor D. Wager, Lars Arendt-Nielsen, Laurie B. Burke, Daniel B. Carr, Amy Chappell, John T. Farrar,